Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Qsymia (Phentermine-topiramate) to Reduce Binge Eating/Purging in Patients With Bulimia Nervosa and Binge Eating Disorder

NCT02553824 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT02553824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02553824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Qsymia (Phentermine-topiramate) to Reduce Binge Eating/Purging in Patients With Bulimia Nervosa and Binge Eating Disorder
Lead sponsor
Stanford University
Phase
Phase 1
Overall status
Completed
Start date
October 30, 2015
Completion date
April 15, 2017
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

binge eating disorder, bulimia nervosa